ASC24
7.2.2024 10:31:30 CET | Business Wire | Press release
The preliminary results for the 2024 ASC Student Supercomputer Challenge (ASC24) have been announced. Over 300 universities worldwide participated, with twenty-five standout teams advancing to the finals. Among the finalists are renowned institutions such as Huazhong University of Science and Technology, Peking University, the Chinese University of Hong Kong, National Tsing Hua University, Friedrich-Alexander-University Erlangen-Nuremberg, and the National University of Cordoba. They will compete for prestigious awards including the Champion, Silver Prize, Group Competition Award, e Prize, and Highest LINPACK at the finals hosted by Shanghai University from April 9 to 13, 2024.
In response to the challenge posed by a large number of excellent teams, the ASC Organizing Committee, and Shanghai University have decided to accommodate 25 teams for the ASC24 Finals, setting a new record for the highest number of teams qualified for onsite finals since the inception of the ASC competition in 2012.
Among the finalists, Huazhong University of Science and Technology's team demonstrated an in-depth grasp of supercomputing knowledge and technologies. Through precise performance bottleneck analysis and innovative optimization methods, they achieved outstanding results. Their exceptional performance across all tasks secured them the top rank in the preliminary round.
The ASC24 finals feature a lineup of traditional powerhouses, including Peking University - the champion of the 10th ASC onsite finals; the Chinese University of Hong Kong - the champion of the 10th ASC virtual finals; University of Science and Technology of China; Shanghai Jiao Tong University; and Friedrich-Alexander-University Erlangen-Nuremberg. Additionally, there is great excitement surrounding the debut of teams from National University of Cordoba, Macau University of Science and Technology, and Southwest Petroleum University, marking their first appearance in the ASC finals this year.
The ASC24 preliminaries included two computational tasks: Large Language Model (LLM) Inference Optimization and Seepage Numerical Simulation. Numerous participating teams excelled, showcasing remarkable capabilities in exploring and innovating in supercomputing application analysis, performance optimization, and parallel strategy design.
In the Large Language Model (LLM) Inference Optimization Challenge, participating teams were assigned the task of building and refining inference engines using the widely used open-source LLM, LLaMA2. The main goal was to achieve high-throughput inference on sample datasets provided by the organizing committee. Teams contending for success were expected to showcase a thorough understanding and proficiency in common parallel methods applicable to LLMs. Furthermore, they were tasked with implementing various techniques to enhance the inference process.
The team from Huazhong University of Science and Technology developed an LLM inference engine that incorporated tensor parallelism, KVCache, and PagedAttention. Additionally, they implemented asynchronous pipelining in parallel to address the issue of incomplete loading of model parameters on a single server. Moreover, they deployed a distributed memory manager on each node to ensure load balancing and conducted numerous comparative experiments to identify the optimal optimization method. These efforts propelled them to achieve the highest score. On the other hand, the team from Friedrich-Alexander-University Erlangen-Nuremberg utilized a customized TensorRT-LLM engine for their cluster. Through various experiments, they determined that a batch size of 8 resulted in twice the throughput compared to a batch size of 1. By leveraging tensor parallelism and batched generation, they achieved good performance.
The Seepage Simulation Task in ASC24 was designed to delve into the intricate flow patterns and characteristics of multiphase fluids within porous media using the open-source software OpenCAEPoro. Participating teams were tasked with simulating the seepage of multiphase fluids, including oil, gas, and water, specifically in scenarios related to petroleum extraction, based on the dataset provided by the organizing committee. The challenge required teams to skillfully optimize large-scale parallel computing processes, with a focus on improving the computing performance and parallel efficiency of discrete algorithms.
The team from Qinghai University utilized common optimization methods, including function inlining, loop expansion, and operator fusion, after conducting a detailed analysis of the seepage simulation software OpenCAEPoro. They also implemented vectorization and memory access optimization to address computational bottleneck matrix assembly, resulting in highly effective optimization. Meanwhile, the National Tsing Hua University team conducted a comprehensive analysis of OpenCAEPoro, pinpointing the primary bottleneck for CPU parallelization. They leveraged optimized compiler flags and computing libraries to achieve the best performance.
About ASC
The ASC Student Supercomputer Challenge is the world's largest student supercomputer competition, sponsored and organized by the Asia Supercomputer Community with support from experts and institutions across Asia, Europe, and America. The main objectives of ASC are to encourage the exchange and training of young supercomputing talent from different countries, improve supercomputing applications and R&D capacity, boost the development of supercomputing, and promote technical and industrial innovation. The first ASC Student Supercomputer Challenge was held in 2012 and has since attracted over 10,000 undergraduates from all over the world. Learn more for ASC at http://www.asc-events.net/StudentChallenge/index.html.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240207108190/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
